Quidelortho Corpoation ($QDEL) Stock Forecast: Up 5.2% Today

What is Quidelortho Corpoation?

Quidel Corporation (QDEL) operates as a provider of diagnostic healthcare solutions, serving various market segments such as infectious diseases, cardiology, and autoimmune diseases.

Why is Quidelortho Corpoation going up?

QDEL stock is up 5.2% on Feb 13, 2025 15:01

• QDEL surpassed estimates with its Q4 earnings and revenues, demonstrating robust financial performance.
• The company's 14.55% earnings surprise and 0.79% revenue beat likely bolstered investor confidence in its growth prospects.
• The strong results indicate high demand for QDEL's diagnostic healthcare solutions, potentially driving the positive stock movement.
• Based on its strong financial performance and growth potential in the healthcare sector, investors may see QDEL as an appealing investment opportunity.

QDEL Price Chart

QDEL Technical Analysis

QDEL News

QuidelOrtho ( QDEL ) Q4 Earnings and Revenues Top Estimates

QuidelOrtho (QDEL) delivered earnings and revenue surprises of 14.55% and 0.79%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2414940/quidelortho-qdel-q4-earnings-and-revenues-top-estimates

Trending Today

MKS Instruments Inc. ($MKSI) Stock Forecast: Down 5.0% Today

Eversource Energy (D/B/A) ($ES) Stock Forecast: Up 5.3% Today

Bittensor ($TAO) Crypto Forecast: Down 5.9% Today

PancakeSwap ($CAKE) Crypto Forecast: Up 5.6% Today

Celestia ($TIA) Crypto Forecast: Down 5.5% Today

Upwork Inc. ($UPWK) Stock Forecast: Up 5.1% Today

CF Industries Holdings Inc. ($CF) Stock Forecast: Down 5.0% Today

American Airlines Group Inc. ($AAL) Stock Forecast: Down 5.3% Today

Memecoin ($MEME) Crypto Forecast: Up 5.3% Today

Delta Air Lines Inc. ($DAL) Stock Forecast: Down 5.0% Today

Quidelortho Corpoation Price History

08.10.2024 - QDEL Stock was up 11.3%

• QDEL's strong bullish movement today is due to the company surpassing Q3 earnings and revenue estimates by a notable margin.
• An earnings surprise of 174.19% and a revenue surprise of 12.75% have probably increased investor confidence in the company's performance.
• This favorable financial report suggests promising growth opportunities for QDEL, potentially attracting more investor attention and driving up the stock price during today's trading session.

08.10.2024 - QDEL Stock was up 12.5%

• QDEL stock experienced a strong bullish movement today.
• The company reported impressive third-quarter earnings and revenue results, surpassing analyst estimates by a significant margin.
• Despite a decline in gross margin, the growth in non-respiratory revenues and cost-cutting measures contributed to the positive performance.
• Investors are optimistic about QDEL's future prospects as the company continues to outperform expectations and demonstrate resilience in a challenging market environment.

22.10.2024 - QDEL Stock was up 5.1%

• Quidel's stock experienced a strong bullish movement today despite significant shares being sold in an underwritten secondary offering.
• The positive market sentiment towards Quidel could be attributed to the company not selling any shares itself, indicating confidence in its current position and future prospects.
• Additionally, the bearish movement of Powell Industries (NASDAQ: POWL) due to weak sales could have led investors to shift their focus towards Quidel, viewing it as a more promising investment option in the healthcare sector.
• Overall, Quidel's resilience in the face of external selling pressure and the contrast with Powell Industries' performance likely contributed to its bullish movement today.

05.08.2024 - QDEL Stock was up 5.2%

• The bullish movement in QDEL's stock price today is linked to the FDA's approval of its new VITROS syphilis assay, which broadens its range of infectious disease testing options.
• Investor optimism may also be contributing to this positive trend, stemming from the company's recent earnings report that highlighted its performance and growth potential.
• The combined effect of the new product clearance and promising financial outlook is likely boosting investor confidence in QDEL, leading to the stock's strong upward movement.

13.10.2024 - QDEL Stock was down 6.2%

• Despite beating earnings and revenue estimates in Q3, QDEL stock saw a strong bearish movement, indicating that the market may have had different expectations.
• The rise in AirSculpt Technologies (NASDAQ:AIRS) and the warning about potential plunging health care stocks could have influenced investor sentiment towards QDEL.
• The decline in gross margin in Q3, despite the positive revenue growth, might have raised concerns among investors about the company's profitability.
• Overall, the market movement of QDEL today could be attributed to a combination of profit-taking after the earnings beat, concerns about margins, and broader sector trends affecting health care stocks.

14.00.2025 - QDEL Stock was down 7.0%

• Despite solid preliminary fourth-quarter revenues meeting expectations, QDEL's stock experienced a bearish movement.
• The market might have been expecting even higher revenues or growth projections, leading to a sell-off.
• Investors could be concerned about future demand for COVID-19 testing products as vaccination rates increase, impacting QDEL's revenue potential.
• The bearish movement could also be influenced by broader market trends or sector rotation, causing investors to reallocate their funds away from healthcare stocks like QDEL.

13.01.2025 - QDEL Stock was up 5.2%

• QDEL surpassed estimates with its Q4 earnings and revenues, demonstrating robust financial performance.
• The company's 14.55% earnings surprise and 0.79% revenue beat likely bolstered investor confidence in its growth prospects.
• The strong results indicate high demand for QDEL's diagnostic healthcare solutions, potentially driving the positive stock movement.
• Based on its strong financial performance and growth potential in the healthcare sector, investors may see QDEL as an appealing investment opportunity.

01.06.2024 - QDEL Stock was down 2.4%

• The release of an investor letter indicating moderate economic growth may have raised concerns about QDEL's growth prospects, leading to selling pressure.
• Entities selling over $4.9 million in QDEL shares could have signaled lack of confidence in the company's future performance, contributing to the bearish trend.
• Underperformance compared to the Russell 2000 Growth index and their decision to sell QDEL shares might have influenced other investors to follow suit, impacting the stock negatively.
• An investigation on behalf of long-term stockholders following a class action complaint could have created uncertainty and fear among investors, further driving down QDEL's stock price.

11.06.2024 - QDEL Stock was up 5.8%

• The bullish movement in QDEL stock could be attributed to the Carlyle Group entities selling over $2.5 million in QuidelOrtho shares.
• This selling activity might have been perceived positively by investors as it could indicate confidence in the company's performance and future prospects.
• The market may have interpreted this move as a strategic decision by Carlyle Group entities, potentially leading to increased investor interest and driving the stock price higher.

16.06.2024 - QDEL Stock was up 5.4%

• Quidel experienced a strong bullish movement possibly due to positive market sentiment towards the healthcare sector.
• The selling of over $2.5 million in QuidelOrtho shares by Carlyle Group entities might have initially caused some uncertainty in the market, but the stock managed to overcome this and surge upwards.
• Mention of National Vision experiencing strength might have contributed to a positive outlook on the healthcare industry as a whole, benefiting Quidel's stock price.
• Despite potential concerns about earnings estimate revisions for National Vision, investors may have viewed Quidel as a more promising investment option, leading to its notable increase in value.

23.06.2024 - QDEL Stock was up 5.0%

• QuidelOrtho's strong product portfolio has raised optimism about the stock, contributing to its bullish movement today.
• The news of Carlyle Group entities selling shares in QuidelOrtho worth over $5.7 million did not seem to have a significant negative impact on the stock's performance, indicating strong underlying bullish sentiment.
• Investors seem to be focusing more on the positive aspects of QuidelOrtho's product portfolio rather than the selling of shares by Carlyle Group entities, driving the stock higher.

15.07.2024 - QDEL Stock was up 5.4%

• Quidel Corporation (QDEL) experienced a strong bullish movement today.
• Suggestions of potential activist campaigns and investigations by legal firms against Quidel Corporation have emerged.
• Market sentiment could be influenced by the company's response to these challenges, demonstrating resilience and operational strength.
• Investors may be optimistic about Quidel's prospects in handling legal issues, which could be driving the upward momentum in the stock price.